Kirsten Schaffer Selected Research

Kirsten Schaffer Research Topics

7	Infections 01/2020 - 12/2012
6	Hypoxia (Hypoxemia) 01/2020 - 12/2010
2	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 11/2017
1	COVID-19 01/2021
1	Endocarditis 01/2018
1	Pneumonia (Pneumonitis) 01/2017
1	Inflammation (Inflammations) 01/2013
1	Infectious Mononucleosis (Glandular Fever) 12/2012
1	Epstein-Barr Virus Infections 12/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2011
1	Liver Diseases (Liver Disease) 12/2011
1	Hepatitis 12/2011
1	Breakthrough Infections 10/2009

4	Oxygen (Dioxygen)IBA 01/2020 - 12/2010
2	AerosolsIBA 01/2021 - 11/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 04/2012
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 04/2012
1	polypentamethylenehexamethylenedicarbamateIBA 01/2020
1	GlycopeptidesIBA 01/2018
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2018
1	Tigecycline (Tygacil)FDA Link 01/2018
1	Daptomycin FDA Link 01/2018
1	Linezolid (Zyvox)FDA Link 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 11/2017
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2017
1	Virulence Factors (Pathogenicity Factors)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2013
1	VaccinesIBA 01/2013
1	NF-kappa B (NF-kB)IBA 01/2013
1	rho-Associated KinasesIBA 01/2013
1	AntigensIBA 12/2012
1	Immunoglobulin G (IgG)IBA 12/2012
1	Valganciclovir FDA Link 10/2009